Seasonal cold infections might generate protective antibodies against COVID-19

Credit: Getty Images
Credit: Getty Images
[S]easonal coronavirus infections occur frequently and typically result in a mild, common cold-like illness. The presence of these coronavirus infections in the population has led to the hypothesis that immune cross-reactivity among these related viruses could occur, and potentially offer some protection to SARS-CoV-2. Now, a group of scientists has detected preexisting antibody-driven immunity against SARS-CoV-2 in a small proportion of individuals who were uninfected at the time of sampling.

The London-based group of researchers found that 16 out of 302 adults (5.3%) harbored IgG antibodies that were likely generated during previous seasonal “common cold” coronavirus infections, and which cross-reacted with subunit S2 of the SARS-CoV-2 spike protein complex.

Notably, the presence of these cross-reactive IgG antibodies was much more prevalent in an additional cohort of SARS-CoV-2-uninfected children and adolescents (aged 1 to 16 years): at least 21 of these 48 subjects (43.8%) had detectable levels of SARS-CoV-2 S-reactive IgG antibodies.

Related article:  Good news for a coronavirus vaccine: Human immune system offers robust response, study shows
Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

Though previous studies suggest cross-reactive immunity is neither sterilizing nor long-lasting, the presence of cross-reactivity can reduce viral transmission and ameliorate symptoms and is, therefore, an important area of study. The authors noted that distinguishing preexisting and de novo immunity “will be critical for our understanding of susceptibility to and the natural course of SARS-CoV-2 infection.”

Read the original post

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend